Lilly's weight-loss pill gets UK regulator's nod - Reuters
Lilly's weight-loss pill gets UK regulator's nod Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNGZUUEFXaGh3M2FrQlNiMVNBek9tTElJR3VITmx0MXljVGNnZnZBUmk3WFZzZzluWnBnUVZrNVh2ZzZwc3ZfNnNEcjNLUUxMbVhOT3JGS1VVUEJ6NUdoMXc0TDd1NTQ2OGZNWjlPWS0yTllEWm1ZWUhYQ1RReU95ek1oVFRTRWJBZjQ5c0l4bERleVNfZjhkQ0ZUeXRyOFBxNHJ3OFRhRU1TNXc?oc=5" target="_blank">Lilly's weight-loss pill gets UK regulator's nod</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMReliance sues India's food regulator over 'energy drink' label ban - Reuters
Reliance sues India's food regulator over 'energy drink' label ban Reuters
October 6, 2026 at 04:18 AMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMEXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say - Reuters
EXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say Reuters
October 7, 2026 at 10:51 AMUK says it will monitor AI-based medical devices continually - Reuters
UK says it will monitor AI-based medical devices continually Reuters
October 5, 2026 at 11:15 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PM